Foulkes WD,Narod SA .1995 .Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med, 18(6) : 473-483.
Rashid MU,Muhammad N,Bajwa S .2016 .Published 2016 Aug 23. BMC Cancer, 16(1) : 673-1180.
Zhu Y,Wu J,Zhang C,Chen C,Xu Y,Huang X,Claes E,Evers-Kiebooms G,Denayer L .2005 .Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure. J Genet Couns, 14(5) : 349-363.
Zorn KK,Tian C,McGuire WP .2017 ."Ascitic Fluid in Ovarian Carcinoma - From Pathophysiology to the Treatment". Cancer, 10(5) : 1028-1035.
. .. , : .
Ahmed N,Stenvers KL,Latifi A,Luwor RB,Bilandzic M .2012 .Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One, 7(10) : e46858.
Rafehi S,Ramos Valdes Y,Bertrand M,Slack-Davis JK,Atkins KA,Harrer C,Hershey ED,Conaway M.,Long KC,Kauff ND .2011 .Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies. Curr Opin Oncol, 23(5) : 526-530.
. .. doi:10, : .